Clinically meaningful classes of financial toxicity for patients with diabetes
2024

Financial Toxicity in Diabetes Patients

Sample size: 600 publication Evidence: high

Author Information

Author(s): Patel Minal R., Troost Jonathan P., Heisler Michele, Carlozzi Noelle E.

Primary Institution: University of Michigan

Hypothesis

Clinically meaningful financial toxicity classes can be identified for diabetes, particularly classes that differentiate between high and low/no financial toxicity.

Conclusion

The COST-FACIT can be used to reliably identify people with diabetes that have high financial toxicity.

Supporting Evidence

  • Three financial toxicity classes (high, medium, low) were identified.
  • High financial toxicity was predicted by multiple indicators of financial stress.
  • A COST-FACIT score of 26 was the strongest threshold for sorting high vs. medium/low financial toxicity.

Takeaway

This study found that some people with diabetes struggle a lot with money because of their health costs, and we can use a special score to help find those who need extra help.

Methodology

Latent Class Analysis was used to identify subgroups of patients based on COST-FACIT score patterns.

Potential Biases

Participants were recruited from a single health system, which may not represent the broader population.

Limitations

The sample was limited to adults with diabetes and high HbA1cs from one health system, which may affect generalizability.

Participant Demographics

Participants were on average 53 years old, 56% female, and 35% reported non-white race.

Statistical Information

P-Value

26

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s41687-024-00834-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication